May 27, 2026 06:49AM
May 22, 2026 05:58AM
May 4, 2026 04:22PM
Apr 10, 2026 04:06PM
Apr 6, 2026 06:53AM
Mar 18, 2026 07:57AM
Mar 17, 2026 05:58PM Stifel Reiterates Buy Rating on Alto Neuroscience (ANRO) as co on track for ph2b TRD study for ALTO-207
Mar 16, 2026 10:56AM
Jan 14, 2026 07:27AM
Jan 5, 2026 07:29AM
Nov 28, 2025 06:03AM
Nov 17, 2025 05:35AM
Nov 13, 2025 04:21AM
Nov 12, 2025 04:50PM Alto Neuroscience, Inc. (ANRO) Tops Q3 EPS by 12c
Oct 24, 2025 06:49AM
Oct 20, 2025 10:59AM
Oct 20, 2025 07:01AM
Sep 29, 2025 05:59AM
Sep 15, 2025 07:37AM
Sep 9, 2025 07:09AM
Aug 13, 2025 06:04PM Alto Neuroscience, Inc. (ANRO) Misses Q2 EPS by 5c
Jun 30, 2025 08:03AM
Jun 27, 2025 06:53AM
Jun 26, 2025 03:09PM
Jun 26, 2025 10:56AM
Jun 26, 2025 07:33AM
Jun 4, 2025 06:47AM
Jun 3, 2025 06:14AM Alto Neuroscience (ANRO) Acquires Novel Dopamine Agonist Combination Product Candidate
May 29, 2025 08:04AM
May 15, 2025 05:33PM
Feb 19, 2025 08:04AM
Feb 12, 2025 10:09AM
Feb 12, 2025 08:04AM
Dec 16, 2024 07:04AM
Nov 13, 2024 04:46PM Alto Neuroscience, Inc. (ANRO) Misses Q3 EPS by 6c
Oct 23, 2024 06:44AM
Oct 23, 2024 06:24AM
Oct 22, 2024 04:44PM
Oct 22, 2024 04:30PM
Sep 10, 2024 08:25AM
Sep 10, 2024 06:30AM
Sep 9, 2024 03:36PM Stifel Recaps Alto Neuroscience (ANRO) Investor Day, 'risk/reward is favorable', Shares Gain ~7.3%
Sep 4, 2024 08:06AM
Sep 3, 2024 06:21AM
Jul 25, 2024 08:34AM
Jun 20, 2024 12:50PM

397,035 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All